XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities    
Net loss $ (101,435) $ (116,503)
Adjustments to reconcile net loss to net cash used by operating activities    
Stock-based compensation 33,215 27,427
Depreciation expense and amortization of intangible assets 7,046 5,332
Bad debt expense 690 561
Amortization of debt issuance costs 342 0
Deferred income taxes (808) (1,549)
Changes in assets and liabilities    
Accounts receivable 30,665 (9,114)
Prepaid expenses and other assets (61,555) (6,723)
Deferred commissions (56) (5,715)
Accounts payable and accrued expenses (657) (3,654)
Accrued compensation and related benefits (6,671) 1,634
Other current and non-current liabilities (2,026) (383)
Deferred revenue (3,186) 15,414
Operating lease assets and liabilities 2,238 (685)
Net cash used by operating activities (102,198) (93,958)
Cash flows from investing activities    
Purchases of investments (53,443) (31,214)
Proceeds from investments 62,590 57,417
Purchases of property and equipment (8,278) (5,861)
Net cash provided by investing activities 869 20,342
Cash flows from financing activities    
Proceeds from borrowings 92,000 0
Debt repayments (2,625) 0
Payments for debt issuance costs (411) 0
Payments for employee taxes related to the net share settlement of equity awards (7,240) 0
Proceeds from exercise of common stock options 664 25,205
Net cash provided by financing activities 82,388 25,205
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash (679) (1,694)
Net decrease in cash, cash equivalents, and restricted cash (19,620) (50,105)
Cash, cash equivalents, and restricted cash at beginning of period 150,381 103,960
Cash, cash equivalents, and restricted cash at end of period 130,761 53,855
Supplemental disclosure of cash flow information    
Cash paid for interest 11,960 243
Cash paid for income taxes 2,944 749
Supplemental disclosure of non-cash investing and financing activities    
Accrued capital expenditures $ 27 $ 317